Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Treatment of a first patient with FLASH-radiotherapy.

Bourhis J, Sozzi WJ, Jorge PG, Gaide O, Bailat C, Duclos F, Patin D, Ozsahin M, Bochud F, Germond JF, Moeckli R, Vozenin MC.

Radiother Oncol. 2019 Oct;139:18-22. doi: 10.1016/j.radonc.2019.06.019. Epub 2019 Jul 11.

PMID:
31303340
2.

[Artificial intelligence and the skin specialist].

Koulouri A, Kuonen F, Gaide O.

Rev Med Suisse. 2019 Mar 27;15(644):687-691. French.

PMID:
30916908
3.

Roger federer pourrait-il jouer en portant un large sombrero ?

Merat R, Gilliet M, Boehncke WH, Gaide O.

Rev Med Suisse. 2018 Aug 8;14(614):1422-1423. French. No abstract available.

PMID:
30091335
4.

TGFβ, Fibronectin and Integrin α5β1 Promote Invasion in Basal Cell Carcinoma.

Kuonen F, Surbeck I, Sarin KY, Dontenwill M, Rüegg C, Gilliet M, Oro AE, Gaide O.

J Invest Dermatol. 2018 Nov;138(11):2432-2442. doi: 10.1016/j.jid.2018.04.029. Epub 2018 Jul 14.

5.

Shed Skin Cancer, Not Collagen XVII: A New Approach to Targeting Skin Cancer Progression.

Gaide O, Hohl D.

Mol Ther. 2018 Jan 3;26(1):8-9. doi: 10.1016/j.ymthe.2017.12.005. Epub 2017 Dec 15. No abstract available.

6.

Evaluation of the National Swiss Skin Cancer Screening Campaign 2013: Do We Do the Right Thing.

Braun RP, Ulrich K, Hunger R, Gaide O, Arnold A, Merat R, Dummer R, Hafner J, French LE, Cozzio A.

Dermatology. 2017;233(5):404-409. doi: 10.1159/000484946. Epub 2017 Dec 14.

7.

[A new vision of skin].

Rakosi A, Kuonen F, Gaide O.

Rev Med Suisse. 2017 Mar 29;13(556):684-690. French.

PMID:
28722378
8.

Dermal γδ T Cells Do Not Freely Re-Circulate Out of Skin and Produce IL-17 to Promote Neutrophil Infiltration during Primary Contact Hypersensitivity.

Jiang X, Park CO, Geddes Sweeney J, Yoo MJ, Gaide O, Kupper TS.

PLoS One. 2017 Jan 12;12(1):e0169397. doi: 10.1371/journal.pone.0169397. eCollection 2017.

9.

Colonisation of basal cell carcinoma by lentigo maligna: a case report, review of the literature, and series follow-up.

Kuonen F, Aschwanden J, Dimaio DJ, Elston DM, Gilliet M, Hohl D, Gaide O.

Eur J Dermatol. 2016 Oct 1;26(5):465-469. Review.

PMID:
27373211
10.

Clues in DeRmoscopy: Dermoscopy of keratoacanthoma.

Kuonen F, Durack A, Gaide O.

Eur J Dermatol. 2016 Aug 1;26(4):419-20. doi: 10.1684/ejd.2016.2842. No abstract available.

PMID:
27528474
11.

Ingenol Mebutate 500 μg for Treatment of the Scalp in Refractory Field Cancerization.

Gaide O, Clayton H, Girardin M, Kuonen F.

Dermatology. 2016;232 Suppl 1:7-8. doi: 10.1159/000447388. Epub 2016 Aug 11.

12.

Ingenol Mebutate 500 µg on the Cheekbones with Concomitant Conjunctivitis.

Gaide O, Cattin V.

Dermatology. 2016;232 Suppl 1:4-6. doi: 10.1159/000447387. Epub 2016 Aug 11.

13.

[Skin memory: the clinical implications].

Gaide O.

Rev Med Suisse. 2016 Mar 30;12(512):631-4. Review. French.

PMID:
27172692
14.

Clues in DeRmoscopy: dermoscopy of angioma serpiginosum.

Kuonen F, Gaide O.

Eur J Dermatol. 2016 Jan-Feb;26(1):118. doi: 10.1684/ejd.2016.2754. No abstract available.

PMID:
27113009
15.

STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.

Demaria O, De Gassart A, Coso S, Gestermann N, Di Domizio J, Flatz L, Gaide O, Michielin O, Hwu P, Petrova TV, Martinon F, Modlin RL, Speiser DE, Gilliet M.

Proc Natl Acad Sci U S A. 2015 Dec 15;112(50):15408-13. doi: 10.1073/pnas.1512832112. Epub 2015 Nov 25.

16.

[New melanoma immunotherapies: mechanisms of action, efficiency and management of toxicities].

Moura B, Homicsko K, Berthod G, Cerottini JP, Guggisberg D, Gaide O, Maillard MH, Michielin O.

Rev Med Suisse. 2015 May 20;11(475):1108, 1110-4. Review. French.

PMID:
26152085
17.

Common clonal origin of central and resident memory T cells following skin immunization.

Gaide O, Emerson RO, Jiang X, Gulati N, Nizza S, Desmarais C, Robins H, Krueger JG, Clark RA, Kupper TS.

Nat Med. 2015 Jun;21(6):647-53. doi: 10.1038/nm.3860. Epub 2015 May 11.

18.

[Skin ulcers in a returning traveler].

Ebiner J, Gaide O, Pedrazzini B.

Praxis (Bern 1994). 2015 Apr 22;104(9):467-9. German.

PMID:
25946756
19.

Residents' corner February 2015. Clues in DeRmoscopy: Dermoscopy of amelanotic cutaneous melanoma metastases.

Kuonen F, Gaide O.

Eur J Dermatol. 2015 Jan-Feb;25(1):97-8. No abstract available.

PMID:
25787722
20.

Swiss clinical practice guidelines on field cancerization of the skin.

Hofbauer G, Anliker M, Boehncke WH, Brand C, Braun R, Gaide O, Hafner J, Hunger R, Itin P, Kaeuper G, Lautenschlager S, Mainetti C, Streit M.

Swiss Med Wkly. 2014 Dec 24;144:w14026. doi: 10.4414/smw.2014.14026. eCollection 2014. Review.

21.

Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity.

Jaworski M, Marsland BJ, Gehrig J, Held W, Favre S, Luther SA, Perroud M, Golshayan D, Gaide O, Thome M.

EMBO J. 2014 Dec 1;33(23):2765-81. doi: 10.15252/embj.201488987. Epub 2014 Oct 15.

22.

Dramatic response of vemurafenib-induced cutaneous lesions upon switch to dual BRAF/MEK inhibition in a metastatic melanoma patient.

Peters S, Bouchaab H, Zimmerman S, Bucher M, Gaide O, Letovanec I, Homicsko K, Michielin O.

Melanoma Res. 2014 Oct;24(5):496-500. doi: 10.1097/CMR.0000000000000055.

PMID:
25185693
23.

[New light on skin photodynamic therapy].

Kuonen F, Gaide O.

Rev Med Suisse. 2014 Apr 2;10(424):754, 756-9. Review. French.

PMID:
24772809
24.

Generation and characterization of function-blocking anti-ectodysplasin A (EDA) monoclonal antibodies that induce ectodermal dysplasia.

Kowalczyk-Quintas C, Willen L, Dang AT, Sarrasin H, Tardivel A, Hermes K, Schneider H, Gaide O, Donzé O, Kirby N, Headon DJ, Schneider P.

J Biol Chem. 2014 Feb 14;289(7):4273-85. doi: 10.1074/jbc.M113.535740. Epub 2014 Jan 3.

25.

Dermoscopy of acral melanoma: a multicenter study on behalf of the international dermoscopy society.

Braun RP, Thomas L, Dusza SW, Gaide O, Menzies S, Dalle S, Blum A, Argenziano G, Zalaudek I, Kopf A, Rabinovitz H, Oliviero M, Perrinaud A, Cabo H, Pizzichetta M, Pozo L, Langford D, Tanaka M, Saida T, Perusquia Ortiz AM, Kreusch J, De Giorgi V, Piccolo D, Grichnik JM, Kittler H, Puig S, Malvehy J, Seidenari S, Stanganelli I, French L, Marghoob AA.

Dermatology. 2013;227(4):373-80. doi: 10.1159/000356178. Epub 2013 Nov 23.

26.

Antagonistic effect of the inflammasome on thymic stromal lymphopoietin expression in the skin.

Schuepbach-Mallepell S, Philippe V, Brüggen MC, Watanabe H, Roques S, Baldeschi C, Gaide O.

J Allergy Clin Immunol. 2013 Dec;132(6):1348-57. doi: 10.1016/j.jaci.2013.06.033. Epub 2013 Aug 13.

PMID:
23953709
27.

Clinical Implications of CD8+ T-cell infiltration in frequent and rare cancers.

Feldmeyer L, Gaide O, Speiser DE.

J Invest Dermatol. 2013 Aug;133(8):1929-32. doi: 10.1038/jid.2013.90.

28.

[Merkel cell carcinoma: (r)evolution].

Feldmeyer L, Gaide O.

Rev Med Suisse. 2013 Apr 3;9(380):723-6, 728-9. French.

PMID:
23621042
29.

TRAIL promotes membrane blebbing, detachment and migration of cells displaying a dysfunctional intrinsic pathway of apoptosis.

Somasekharan SP, Koc M, Morizot A, Micheau O, Sorensen PH, Gaide O, Andera L, Martinou JC.

Apoptosis. 2013 Mar;18(3):324-36. doi: 10.1007/s10495-012-0782-6.

PMID:
23179179
30.

TNF-α and IFN-γ are potential inducers of Fas-mediated keratinocyte apoptosis through activation of inducible nitric oxide synthase in toxic epidermal necrolysis.

Viard-Leveugle I, Gaide O, Jankovic D, Feldmeyer L, Kerl K, Pickard C, Roques S, Friedmann PS, Contassot E, French LE.

J Invest Dermatol. 2013 Feb;133(2):489-98. doi: 10.1038/jid.2012.330. Epub 2012 Sep 20.

31.

Membrane-bound TNF induces protective immune responses to M. bovis BCG infection: regulation of memTNF and TNF receptors comparing two memTNF molecules.

Olleros ML, Vesin D, Bisig R, Santiago-Raber ML, Schuepbach-Mallepell S, Kollias G, Gaide O, Garcia I.

PLoS One. 2012;7(5):e31469. doi: 10.1371/journal.pone.0031469. Epub 2012 May 30.

32.

Molecular and therapeutic characterization of anti-ectodysplasin A receptor (EDAR) agonist monoclonal antibodies.

Kowalczyk C, Dunkel N, Willen L, Casal ML, Mauldin EA, Gaide O, Tardivel A, Badic G, Etter AL, Favre M, Jefferson DM, Headon DJ, Demotz S, Schneider P.

J Biol Chem. 2011 Sep 2;286(35):30769-79. doi: 10.1074/jbc.M111.267997. Epub 2011 Jul 5.

33.

PIDD orchestrates translesion DNA synthesis in response to UV irradiation.

Logette E, Schuepbach-Mallepell S, Eckert MJ, Leo XH, Jaccard B, Manzl C, Tardivel A, Villunger A, Quadroni M, Gaide O, Tschopp J.

Cell Death Differ. 2011 Jun;18(6):1036-45. doi: 10.1038/cdd.2011.19. Epub 2011 Mar 18.

34.

Classifying ectodermal dysplasias: Incorporating the molecular basis and pathways (Workshop II).

Wright JT, Morris C, Clements SE, D'Souza R, Gaide O, Mikkola M, Zonana J.

Am J Med Genet A. 2009 Sep;149A(9):2062-7. doi: 10.1002/ajmg.a.32869.

PMID:
19681147
35.

Gene therapy and protein therapy of ectodermal dysplasias: a perspective.

Gaide O.

Am J Med Genet A. 2009 Sep;149A(9):2042-4. doi: 10.1002/ajmg.a.32839.

PMID:
19681129
36.

2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) poisoning in Victor Yushchenko: identification and measurement of TCDD metabolites.

Sorg O, Zennegg M, Schmid P, Fedosyuk R, Valikhnovskyi R, Gaide O, Kniazevych V, Saurat JH.

Lancet. 2009 Oct 3;374(9696):1179-85. doi: 10.1016/S0140-6736(09)60912-0. Epub 2009 Aug 5. Review.

PMID:
19660807
37.

Biological activity of ectodysplasin A is conditioned by its collagen and heparan sulfate proteoglycan-binding domains.

Swee LK, Ingold-Salamin K, Tardivel A, Willen L, Gaide O, Favre M, Demotz S, Mikkola M, Schneider P.

J Biol Chem. 2009 Oct 2;284(40):27567-76. doi: 10.1074/jbc.M109.042259. Epub 2009 Aug 5.

38.

Neonatal treatment with recombinant ectodysplasin prevents respiratory disease in dogs with X-linked ectodermal dysplasia.

Mauldin EA, Gaide O, Schneider P, Casal ML.

Am J Med Genet A. 2009 Sep;149A(9):2045-9. doi: 10.1002/ajmg.a.32916.

39.

Community-acquired methicillin-resistant Staphylococcus aureus infections in two scuba divers returning from the Philippines.

Bochet M, Francois P, Longtin Y, Gaide O, Renzi G, Harbarth S.

J Travel Med. 2008 Sep-Oct;15(5):378-81. doi: 10.1111/j.1708-8305.2008.00243.x.

40.

[Inflammation and auto-immunity: an update on the NOD-like receptors and their clinical role].

Gaide O.

Rev Med Suisse. 2008 Apr 30;4(155):1103-6. Review. French.

PMID:
18610723
41.

Danger signaling through the inflammasome acts as a master switch between tolerance and sensitization.

Watanabe H, Gehrke S, Contassot E, Roques S, Tschopp J, Friedmann PS, French LE, Gaide O.

J Immunol. 2008 May 1;180(9):5826-32.

42.

Resistance to FasL and tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in Sezary syndrome T-cells associated with impaired death receptor and FLICE-inhibitory protein expression.

Contassot E, Kerl K, Roques S, Shane R, Gaide O, Dupuis M, Rook AH, French LE.

Blood. 2008 May 1;111(9):4780-7. doi: 10.1182/blood-2007-08-109074. Epub 2008 Feb 26.

43.

The proteolytic activity of the paracaspase MALT1 is key in T cell activation.

Rebeaud F, Hailfinger S, Posevitz-Fejfar A, Tapernoux M, Moser R, Rueda D, Gaide O, Guzzardi M, Iancu EM, Rufer N, Fasel N, Thome M.

Nat Immunol. 2008 Mar;9(3):272-81. doi: 10.1038/ni1568. Epub 2008 Feb 10.

PMID:
18264101
44.

Insight into the inflammasome and caspase-activating mechanisms.

Gaide O, Hoffman HM.

Expert Rev Clin Immunol. 2008 Jan;4(1):61-77. doi: 10.1586/1744666X.4.1.61.

PMID:
20477588
45.

Significant correction of disease after postnatal administration of recombinant ectodysplasin A in canine X-linked ectodermal dysplasia.

Casal ML, Lewis JR, Mauldin EA, Tardivel A, Ingold K, Favre M, Paradies F, Demotz S, Gaide O, Schneider P.

Am J Hum Genet. 2007 Nov;81(5):1050-6. Epub 2007 Sep 18.

46.

Death receptors and apoptosis.

Contassot E, Gaide O, French LE.

Dermatol Clin. 2007 Oct;25(4):487-501, vii. Review.

PMID:
17903608
47.

Exclusively benign dermoscopic pattern in a patient with acral melanoma.

Braun RP, Gaide O, Skaria AM, Kopf AW, Saurat JH, Marghoob AA.

Arch Dermatol. 2007 Sep;143(9):1213-5; author reply 1215-6. No abstract available.

PMID:
17875894
48.

Can automated dermoscopy image analysis instruments provide added benefit for the dermatologist? A study comparing the results of three systems.

Perrinaud A, Gaide O, French LE, Saurat JH, Marghoob AA, Braun RP.

Br J Dermatol. 2007 Nov;157(5):926-33. Epub 2007 Sep 13.

PMID:
17854361
49.

The significance of multiple blue-grey dots (granularity) for the dermoscopic diagnosis of melanoma.

Braun RP, Gaide O, Oliviero M, Kopf AW, French LE, Saurat JH, Rabinovitz HS.

Br J Dermatol. 2007 Nov;157(5):907-13. Epub 2007 Aug 24.

PMID:
17725673
50.

NALP inflammasomes: a central role in innate immunity.

Martinon F, Gaide O, Pétrilli V, Mayor A, Tschopp J.

Semin Immunopathol. 2007 Sep;29(3):213-29. Epub 2007 Aug 17. Review.

PMID:
17703304

Supplemental Content

Support Center